Takeda Pharmaceutical

+$0.13 (+0.78%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TAK and other stocks, options, and ETFs commission-free!

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other.

CEO
Christophe Weber
Employees
47,495
Headquarters
Osaka, Osaka
Founded
1781

TAK Key Statistics

Market Cap
53.03B
Price-Earnings Ratio
31.06
Dividend Yield
4.57
Average Volume
2.40M
High Today
$17.01
Low Today
$16.80
Open Price
$16.80
Volume
2.10M
52 Week High
$20.00
52 Week Low
$15.30

TAK News

ReutersMay 11

Takeda says it may double imports of Moderna shots to help accelerate Japan vaccination

Takeda Pharmaceutical Co (4502.T) on Tuesday said it may double imports of Moderna Inc's (MRNA.O) COVID-19 vaccine to help Japan speed up COVID-19 inoculation e
ReutersMay 11

Japan's Takeda Pharma says full-year profit up five-fold

TOKYO, May 11 (Reuters) - Takeda Pharmaceutical Co said on Tuesday that full-year operating profit jumped five-fold from the previous year, driven by sales of i
Nikkei Asian ReviewMay 10

Shionogi says looking to provide COVID-19 vaccine this year

OSAKA (Kyodo) -- Japanese drugmaker Shionogi is expecting to provide a coronavirus vaccine within the year if conditions are met, its president said Monday. It

TAK Earnings

$0.00
$0.38
$0.76
$1.14
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected May 25, After Hours
Replay Earnings Call

You May Also Like

ISMD

More TAK News

Nikkei Asian ReviewMay 9

Takeda bets on Japan R&D hub for next blockbuster drug

TOKYO -- Takeda Pharmaceutical's state-of-the-art research and development center in the waterfront city of Shonan has yet to yield a blockbuster treatment sinc
ReutersMay 7

Novavax expects COVID-19 vaccine supply in Japan to begin in late 2021

May 7 (Reuters) - Novavax Inc said on Friday the distribution of its COVID-19 vaccine in Japan is expected to begin in late 2021 or early 2022. Takeda Pharmace
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure